Home United Therapeutics submits pre-market approval application for use...
 

Keywords :   


United Therapeutics submits pre-market approval application for use...

2014-12-26 10:50:53| Biotech - Topix.net

United Therapeutics Corporation announced today that Medtronic, Inc. has submitted a pre-market approval application to the U.S. Food and Drug Administration for the use of Medtronic's SynchroMedA II implantable drug infusion system for use with United Therapeutics' RemodulinA Injection delivered intravenously to patients with pulmonary arterial hypertension.

Tags: use united application approval

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.11110
27.11RIIZE BIGM
27.11BOX+BOX+2
27.11! 138
27.11 24
27.11702
27.11HOWL
27.11 THE CELL 5
More »